Cover Image

Insertional diversification of the immunoglobulin heavy chain in chronic lymphoproliferative disorders

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Amelia Fisher, Jane Shingles, Darren Newton, Reuben Tooze
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ras‐associated autoimmune lymphoproliferative disorder
by: Kathleen E. Sullivan, et al.
Published: (2024)

Management of immunosuppression in post‐transplant lymphoproliferative disorders treated with CAR T cells
by: Nathacha Jimkap, et al.
Published: (2024)

Glofitamab in refractory Burkitt lymphoma‐type post‐transplant lymphoproliferative disorder
by: Ho Pui Jeff Lam, et al.
Published: (2026)

Concurrence of mixed cryoglobulinaemia and cold agglutinin disease, and the putative role for a stereotyped immunoglobulin light chain
by: Ylenia A. Minafò, et al.
Published: (2025)

Impaired apoptosis underlying lymphoproliferative disease in a patient with haploinsufficient NFKB1 deficiency
by: Lucie Roussel, et al.
Published: (2024)

When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?
by: Sydney Dubois, et al.
Published: (2024)

Distinct subtypes of post‐transplant lymphoproliferative disorders: CHIP‐like mutations in early lesions and substantial mutational differences between EBV‐positive and EBV‐negative diffuse large B‐cell lymphomas
by: Vanesa‐Sindi Ivanova, et al.
Published: (2025)

Are we there yet? CAR ‐T therapy in multiple myeloma
by: Eitan Mirvis, et al.
Published: (2024)

COVID ‐19‐related mortality in a real‐world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK 's Haematological Malignancy Research Network
by: Alexandra Smith, et al.
Published: (2025)

Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH‐TC study
by: Javier Cornago, et al.
Published: (2026)

Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease
by: Divaya Bhutani, et al.
Published: (2024)

Proteomic profiling of circulating β‐thalassaemia/haemoglobin E extra‐cellular vesicles reveals that association with immunoglobulin induces membrane vesiculation
by: Kunwadee Phongpao, et al.
Published: (2024)

Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia
by: Simone Claudiani, et al.
Published: (2026)

The Mozart effect in chronic myeloid leukaemia
by: Jesper Stentoft
Published: (2024)

Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients
by: Vincent Alcazer, et al.
Published: (2024)

Response rates to second‐line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib‐based regime
by: Joshua Bomsztyk, et al.
Published: (2024)

Cognitive impairment among patients with chronic immune thrombocytopenia
by: David J. Kuter, et al.
Published: (2024)

Very long‐term outcomes of chronic‐phase chronic myeloid leukaemia patients treated with imatinib: A 25‐year real‐world cohort study
by: Alessandro Costa, et al.
Published: (2026)

Haematoidin in chronic myelomonocytic leukaemia during irregular treatment with hydroxycarbamide
by: Xiaohui Zhang, et al.
Published: (2024)

Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype
by: Andrea Serafin, et al.
Published: (2025)

Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
by: Tuan Hoang, et al.
Published: (2025)

An old leukaemia in young patients—Genetic characteristics of paediatric chronic myeloid leukaemia
by: Markus Metzler, et al.
Published: (2025)

Measurable residual disease‐driven treatment in first‐line chronic lymphocytic leukaemia
by: M. S. Davids, et al.
Published: (2024)

Mixed histiocytic disorders: Nature versus nurture?
by: Kenneth McClain, et al.
Published: (2024)

Predictors of renal response in AL amyloidosis following anti‐plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype
by: Matthew J. Rees, et al.
Published: (2026)

Anti‐PF4 disorders: Pathogenesis, diagnosis and treatment
by: Megan V. Preece, et al.
Published: (2025)

Diagnostic delay of MYH9‐related disorder in Japan
by: Atsushi Sakamoto, et al.
Published: (2024)

EPAS1 ‐mutated paragangliomas associated with haemoglobin disorders
by: Maxence Mancini, et al.
Published: (2024)

Peripheral blood profiling of azacitidine's hypomethylation: Advancing precision medicine in juvenile chronic myelomonocytic leukaemia
by: Pasquale Niscola
Published: (2025)

Pericardial events associated with ibrutinib‐based therapies for chronic lymphocytic leukaemia in two landmark trials
by: Bita Fakhri, et al.
Published: (2024)

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
by: Francesca Perutelli, et al.
Published: (2025)

Elranatamab therapy in relapsed refractory multiple myeloma patients with chronic kidney disease: A case series
by: Gráinne Marron, et al.
Published: (2026)

Dapsone for paediatric chronic immune thrombocytopenia: Short report from a tertiary centre in South India
by: Niteesh Bharadwaj, et al.
Published: (2024)

Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction
by: Chenyu Lin, et al.
Published: (2024)

Second primary malignancies in Asian chronic lymphocytic leukaemia patients: A Taiwan Cancer Registry Study
by: Yi‐Wei Lee, et al.
Published: (2026)

Precision transplant and cell therapies for non‐malignant disorders—The path forward
by: Madhavi Lakkaraja, et al.
Published: (2025)

Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorder
by: Aurelio Maggio, et al.
Published: (2024)

Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia
by: Beth MacLean, et al.
Published: (2025)

Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies
by: Michael R. Savona, et al.
Published: (2025)

Treatment‐free remission in chronic myeloid leukaemia patients with accelerated phase or tyrosine kinase inhibitor therapy failure
by: Mengyao Yuan, et al.
Published: (2025)